Lite Strategy, Inc. — Director's Dealing 2025

Jul 18, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEI Pharma, Inc. (MEIP)
CIK: 0001262104
Period of Report: 2025-07-15

Reporting Person: Glover Nicholas (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-07-15	Stock Option (Right to Buy)	$3.07	A	20000	Acquired	2035-07-15	Common Stock (20000)	Direct

Footnotes

F1: Customary annual grant to non-employee directors of options to purchase shares of common stock was not made during the fiscal year ended June 30, 2025.